Birth Outcomes · Maternal Mortality
Serious and deadly complications from pregnancy after endometrial ablation: two case reports and review of the literature
Laberge PY, 2008
472 works
Pregnancy
Progesterone support, miscarriage prevention, preterm birth, and outcomes for mother and baby.
In Pregnancy
472 works
Safety and Risks · Neonatal and Birth Outcomes
Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study
Romundstad LB et al., 2008
Safety and Risks · Maternal Complications
Maternal morbidity and mortality in in-vitro fertilization
Källén B, 2008
Birth Outcomes · Maternal Morbidity
Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality
Luke B et al., 2007
Fertility and Outcomes · Conception After Excision
Endometriosis is associated with a decreased risk of pre-eclampsia
Brosens IA et al., 2007
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Metformin reduces abortion in pregnant women with polycystic ovary syndrome
Khattab S et al., 2006
Reproductive Genetics · Chromosomal Abnormalities
The association between preeclampsia and placental trisomy 16 mosaicism
Yong PJ et al., 2006
Metabolic and Endocrine Agents · Thyroid Replacement
Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications
Negro R et al., 2006
Outcomes and Effectiveness · Live Birth Rates
Outcomes from assisted reproductive technology
Van Voorhis BJ, 2006
Birth Outcomes · Maternal Morbidity
In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality
Källén B et al., 2005
Ovarian Hormones · Estrogen
Lepidium meyenii (Maca) increases litter size in normal adult female mice
Ruiz-Luna AC et al., 2005
Anti-Infective and Anti-Inflammatory Agents · Immune Modulating Agents
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson M et al., 2005
Prescribing Safety · Medication Safety in Pregnancy
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study
Einarson A et al., 2004
Birth Outcomes · Maternal Morbidity
Obesity, obstetric complications and cesarean delivery rate--a population-based screening study
Weiss JL et al., 2004
Ovarian Hormones · Progesterone
Chapter 54: Assessing Progesterone During Pregnancy
Hilgers TW, 2004 Book chapter
Guidelines by Clinical Area · Obstetric Guidelines
ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor
ACOG, 2003
Infections · Vaginal and Cervical Infections
First-trimester pregnancy loss and active Chlamydia trachomatis infection: correlation and ultrastructural evidence
Vigil P et al., 2002
Birth Outcomes · Maternal Morbidity
Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age
Paulson RJ et al., 2002
Anti-Infective and Anti-Inflammatory Agents · Immune Modulating Agents
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment
Farquharson RG et al., 2002
Recurrent Pregnancy Loss · Endocrine Causes
Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss
Craig LB et al., 2002
Safety and Risks · Neonatal and Birth Outcomes
Low and very low birth weight in infants conceived with use of assisted reproductive technology
Schieve LA et al., 2002
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome
Glueck CJ et al., 2002
Safety and Risks · Neonatal and Birth Outcomes
Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999)
Bonduelle M et al., 2002
Safety and Risks · Maternal Complications
Preeclampsia in multiple gestation: the role of assisted reproductive technologies
Lynch A et al., 2002
Luteal Phase · Corpus Luteum Function
Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization
Wulff C et al., 2001
Anti-Infective and Anti-Inflammatory Agents · Immune Modulating Agents
Obstetric uses of intravenous immunoglobulin: successes, failures, and promises
Branch DW et al., 2001
Cost of Care · Cost Effectiveness
A randomized trial of nurse specialist home care for women with high-risk pregnancies: outcomes and costs
Brooten D et al., 2001
Hormonal Agents · Progesterone and Progestins
A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles
Costabile L et al., 2001
Safety and Risks · Neonatal and Birth Outcomes
Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report
Olivennes F et al., 2001
Hormonal Agents · Gonadotropins
A proposed role for hCG in clinical obstetrics
Kurtzman JT et al., 2001
Luteal Phase · Corpus Luteum Function
On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation
Licht P et al., 2001
Safety and Risks · Neonatal and Birth Outcomes
Neonatal outcome of spontaneous and assisted twin pregnancies
Zuppa AA et al., 2001
Metabolic and Endocrine Agents · Insulin Sensitizing Agents
Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study
Glueck CJ et al., 2001
Birth Outcomes · Maternal Morbidity
Polycystic ovary disease and the risk of pregnancy-induced hypertension
Kashyap S et al., 2000
Cervical Conditions · Cervical Insufficiency
Change in cervical length after cerclage as a predictor of preterm delivery
Dijkstra K et al., 2000
Luteal Phase · Luteal Phase Deficiency
Luteal estrogen supplementation in pregnancies associated with low serum estradiol concentrations
Kaider AS et al., 2000
Safety and Risks · Multiple Gestation
Contribution of assisted reproductive technology and ovulation-inducing drugs to triplet and higher-order multiple births--United States, 1980-1997
CDC, 2000 Report
Labor and Birth · Induction of Labor
Treatment of Preterm Labor with Human Chorionic Gonadotropin: A New Modality
Ali AFM et al., 2000
Safety and Risks · Neonatal and Birth Outcomes
Effects of in vitro fertilization on low birth weight, preterm delivery, and multiple birth
Tough SC et al., 2000
Outcomes and Effectiveness · Outcomes by Diagnosis
Obstetric outcome of pregnancies following ICSI, classified according to sperm origin and quality
Wennerholm UB et al., 2000
Labor and Birth · Induction of Labor
Indomethacin for preterm labor: a randomized comparison of vaginal and rectal-oral routes
Abramov Y et al., 2000
Birth Outcomes · Maternal Morbidity
Induced abortion and subsequent pregnancy duration
Zhou W et al., 1999
Anti-Infective and Anti-Inflammatory Agents · Nonsteroidal Anti-Inflammatory Drugs
Tocolytics for preterm labor: a systematic review
Gyetvai K et al., 1999
Anti-Infective and Anti-Inflammatory Agents · Antibiotics in Reproductive Care
Antibiotic use in pregnancy and drug-resistant infant sepsis
Mercer BM et al., 1999
Birth Outcomes · Maternal Morbidity
Is adolescent pregnancy associated with adverse perinatal outcome?
Orvos H et al., 1999
Donor Gametes and Surrogacy · Donor Conceived Outcomes
The influence of donated gametes on the incidence of hypertensive disorders of pregnancy
Salha O et al., 1999
Cervical Conditions · Cervical Insufficiency
Change in cervical length after prophylactic cerclage
Funai EF et al., 1999
Measurement and Statistics · Research Tooling and Reproducibility
Pitfalls in ultrasonic cervical length measurement for predicting preterm birth
Yost NP et al., 1999
Cervical Conditions · Cervical Insufficiency
The effect of therapeutic McDonald cerclage on cervical length as assessed by transvaginal ultrasonography
Althuisius SM et al., 1999
Prescribing Safety · Off-Label Prescribing
Clinical issues surrounding the use of terbutaline sulfate for preterm labor
Lam F et al., 1998
Safety and Risks · Procedural Safety
Complications of medically assisted conception in 3,500 cycles
Serour GI et al., 1998
Anti-Infective and Anti-Inflammatory Agents · Antibiotics in Reproductive Care
Potential consequences of widespread antepartal use of ampicillin
Towers CV et al., 1998
Birth Setting and Provider · Birth Center and Home Birth
Outcomes of intended home births in nurse-midwifery practice: a prospective descriptive study
Murphy PA; Fullerton J, 1998
Infections · Pelvic Inflammatory Disease
[Intrauterine infections. I. The role of C-reactive protein, white blood cell count and erythrocyte sedimentation rate in pregnant women in the detection of intrauterine infection after preliminary rupture of membranes]
Nowak M et al., 1998
Ovarian Hormones · Progesterone
Expression of gelatinase B by trophoblast cells: down-regulation by progesterone
Shimonovitz S et al., 1998
Birth Outcomes · Maternal Morbidity
Should multifetal pregnancy reduction be used for prevention of preterm deliveries in triplet or higher order multiple pregnancies?
Papiernik E et al., 1998
Donor Gametes and Surrogacy · Sperm and Embryo Donation
Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility
Smith GN et al., 1997
Thyroid and Metabolic Function · Insulin and Metabolism
Pregnancy in infertile PCOD patients. Complications and outcome
Urman B et al., 1997
Birth Outcomes · Maternal Morbidity
Is the obstetric outcome of in vitro fertilized singleton gestations different from natural ones? A controlled study
Reubinoff BE et al., 1997
Preclinical Research · Laboratory Methods
Interleukin-8 in urine: a new diagnostic parameter for intra-amniotic infection after premature rupture of the membranes
Stiemer B et al., 1997
